331 related articles for article (PubMed ID: 26980486)
1. The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration.
Anastasiadou S; Knöll B
Exp Neurol; 2016 May; 279():243-260. PubMed ID: 26980486
[TBL] [Abstract][Full Text] [Related]
2. CNS axon regeneration inhibitors stimulate an immediate early gene response via MAP kinase-SRF signaling.
Stern S; Knöll B
Mol Brain; 2014 Nov; 7():86. PubMed ID: 25406759
[TBL] [Abstract][Full Text] [Related]
3. Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV.
Geffin R; Martinez R; de Las Pozas A; Issac B; McCarthy M
J Neurovirol; 2017 Dec; 23(6):808-824. PubMed ID: 28913617
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
[TBL] [Abstract][Full Text] [Related]
5. The transcription factor serum response factor stimulates axon regeneration through cytoplasmic localization and cofilin interaction.
Stern S; Haverkamp S; Sinske D; Tedeschi A; Naumann U; Di Giovanni S; Kochanek S; Nordheim A; Knöll B
J Neurosci; 2013 Nov; 33(48):18836-48. PubMed ID: 24285890
[TBL] [Abstract][Full Text] [Related]
6. FTY720 (fingolimod) regulates key target genes essential for inflammation in microglial cells as defined by high-resolution mRNA sequencing.
Das A; Arifuzzaman S; Kim SH; Lee YS; Jung KH; Chai YG
Neuropharmacology; 2017 Jun; 119():1-14. PubMed ID: 28373076
[TBL] [Abstract][Full Text] [Related]
7. Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
Ottenlinger F; Schwiebs A; Pfarr K; Wagner A; Grüner S; Mayer CA; Pfeilschifter JM; Radeke HH
Eur J Immunol; 2016 Apr; 46(4):941-51. PubMed ID: 26683421
[TBL] [Abstract][Full Text] [Related]
8. Computer design, synthesis, and bioactivity analyses of drugs like fingolimod used in the treatment of multiple sclerosis.
Turgut GÇ; Doyduk D; Yıldırır Y; Yavuz S; Akdemir A; Dişli A; Şen A
Bioorg Med Chem; 2017 Jan; 25(2):483-495. PubMed ID: 27913115
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation.
Mazzola MA; Raheja R; Murugaiyan G; Rajabi H; Kumar D; Pertel T; Regev K; Griffin R; Aly L; Kivisakk P; Nejad P; Patel B; Gwanyalla N; Hei H; Glanz B; Chitnis T; Weiner HL; Gandhi R
J Neuroinflammation; 2015 Dec; 12():245. PubMed ID: 26714756
[TBL] [Abstract][Full Text] [Related]
10. Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling.
Szepanowski F; Derksen A; Steiner I; Meyer Zu Hörste G; Daldrup T; Hartung HP; Kieseier BC
J Neuroinflammation; 2016 Jun; 13(1):143. PubMed ID: 27283020
[TBL] [Abstract][Full Text] [Related]
11. Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model.
Schuhmann MK; Bittner S; Meuth SG; Kleinschnitz C; Fluri F
Int J Mol Sci; 2015 Dec; 16(12):29454-66. PubMed ID: 26690412
[TBL] [Abstract][Full Text] [Related]
12. Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons.
Bomze HM; Bulsara KR; Iskandar BJ; Caroni P; Skene JH
Nat Neurosci; 2001 Jan; 4(1):38-43. PubMed ID: 11135643
[TBL] [Abstract][Full Text] [Related]
13. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses.
Papadopoulos D; Rundle J; Patel R; Marshall I; Stretton J; Eaton R; Richardson JC; Gonzalez MI; Philpott KL; Reynolds R
J Neurosci Res; 2010 Feb; 88(2):346-59. PubMed ID: 19658199
[TBL] [Abstract][Full Text] [Related]
14. Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
Schröder M; Arlt O; Schmidt H; Huwiler A; Angioni C; Pfeilschifter JM; Schwiebs A; Radeke HH
Biol Chem; 2015 Jun; 396(6-7):795-802. PubMed ID: 25720062
[TBL] [Abstract][Full Text] [Related]
15. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation.
Tsai HC; Huang Y; Garris CS; Moreno MA; Griffin CW; Han MH
JCI Insight; 2016 Jun; 1(9):e86462. PubMed ID: 27699272
[TBL] [Abstract][Full Text] [Related]
16. Fingolimod (FTY720) prevents chronic rejection of rodent cardiac allografts through inhibition of the RhoA pathway.
Chen W; Chen W; Chen S; Uosef A; Ghobrial RM; Kloc M
Transpl Immunol; 2021 Apr; 65():101347. PubMed ID: 33131698
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo.
Hu Y; Lee X; Ji B; Guckian K; Apicco D; Pepinsky RB; Miller RH; Mi S
Mol Cell Neurosci; 2011 Sep; 48(1):72-81. PubMed ID: 21740973
[TBL] [Abstract][Full Text] [Related]
18. Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype.
Heinen A; Beyer F; Tzekova N; Hartung HP; Küry P
Exp Neurol; 2015 Sep; 271():25-35. PubMed ID: 25957629
[TBL] [Abstract][Full Text] [Related]
19. FTY720 attenuates excitotoxicity and neuroinflammation.
Cipriani R; Chara JC; Rodríguez-Antigüedad A; Matute C
J Neuroinflammation; 2015 May; 12():86. PubMed ID: 25953296
[TBL] [Abstract][Full Text] [Related]
20. Ephrin-A5 suppresses neurotrophin evoked neuronal motility, ERK activation and gene expression.
Meier C; Anastasiadou S; Knöll B
PLoS One; 2011; 6(10):e26089. PubMed ID: 22022520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
